Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 355,301 $ 118,065,699 $ (122,594,000) $ (4,173,000)
Beginning balance, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 6,040 52,960 59,000
Common stock issued on conversion of notes payable, shares 6,040,049      
Warrants issued with convertible notes 283,000 283,000
Common stock issued on exercise of warrants $ 14,484 527,516 542,000
Common stock issued on exercise of warrants, shares 14,483,825      
Fair value of options and warrants issued as compensation 127,000 127,000
Common stock issued on exercise of options $ 250 19,750 20,000
Common stock issued on exercise of options, shares 250,000      
Net loss (1,548,000) (1,548,000)
Ending balance, value at Dec. 31, 2022 $ 376,075 119,075,925 (124,142,000) (4,690,000)
Ending balance, shares at Dec. 31, 2022 376,074,096      
Common stock issued on conversion of notes payable $ 15,129 334,871 350,000
Common stock issued on conversion of notes payable, shares 15,129,048      
Warrants issued with convertible notes 231,000 231,000
Common stock issued on exercise of warrants $ 1,383 50,617 52,000
Common stock issued on exercise of warrants, shares 1,383,327      
Fair value of warrants issued as compensation 37,000 37,000
Net loss (1,224,000) (1,224,000)
Ending balance, value at Dec. 31, 2023 $ 392,587 $ 119,729,413 $ (125,366,000) $ (5,244,000)
Ending balance, shares at Dec. 31, 2023 392,586,471